Daniel Whitehurst

Daniel Whitehurst, MD


  • Clinical Fellow, Division of Infectious Diseases
As an infectious diseases doctor, my goal is to improve the life of every child I see.
Daniel Whitehurst, MD

About

Biography

I am a clinical fellow specializing in pediatric infectious diseases. I strive to provide thoughtful, evidence-based care. My goal is to balance the best available science with the unique needs of each child and family. As a pediatric infectious disease specialist, I diagnose and treat complex infections. I aim to ensure that medications and diagnostic tests treat infections without causing harm.

I have always been curious about science, have a passion for problem-solving and a desire to make a meaningful impact. I chose pediatrics as we can fix most pediatric conditions, especially infections. As an infectious diseases doctor, my goal is to improve the life of every child I see.

I value the physician-child-patient relationship and am honored by the trust parents place in us when we care for their kids. I believe in open communication and partnering with families. I explain medical decisions so that parents feel informed and empowered in their child’s care.

My research aims to improve the sharing and availability of medical knowledge. We store a lot of important information in the electronic medical record (EMR), but accessing this information to improve patient care is challenging. I want to make it easier to use the information we collect to improve our ability to choose better medications for kids.

When I am not at work, I enjoy going for a long run or bike ride. I like to cook and try new foods, especially while traveling with my wife. I also like to fix and improve things around the house.

BS: University of Pittsburgh, Pittsburgh, PA.

MD: Vanderbilt University School of Medicine, Nashville, TN.

Residency: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Interests

Pediatric infectious diseases; clinical informatics

Services and Specialties

Interests

Pediatric infectious diseases; clinical informatics

Publications

Emapalumab for Maladaptive Interferon-γ-Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First-Line Antituberculosis Therapy. Almodallal, Y; Whitehurst, D; Way, SS; Koo, J; Kumar, AR. Pediatric Blood and Cancer. 2025; 72:e32052.

Polymerase chain reaction fails to detect mixed malaria infections in siblings from Ethiopia. Hall, AD; Whitehurst, DA; Mortensen, JE; Prus, K; Staat, MA; Schlaudecker, EP; Prasanphanich, NS. Journal of Infection and Chemotherapy. 2025; 31:102777.

Clinical Impact of Bronchoalveolar Lavage in Pediatric and Young Adult Patients With Cancer and Suspected Respiratory Infections. Whitehurst, D; Otto, W; Verkamp, B; Paulsen, G; Danziger-Isakov, L; Miller-Handley, H. Journal of the Pediatric Infectious Diseases Society. 2025; 14:piae124.

Disseminated Disease After Candidemia in Children and Young Adults: Epidemiology, Diagnostic Evaluation and Risk Factors. Murphy, CR; Teoh, Z; Whitehurst, D; Brammer, C; Perkins, K; Paulsen, G; Miller-Handley, H; Danziger-Isakov, L; Otto, WR. The Pediatric Infectious Disease Journal. 2024; 43:328-332.

A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients. Whitehurst, DA; Friedman, DL; Zhao, Z; Sarma, A; Snyder, E; Dulek, DE; Banerjee, R; Kitko, CL; Esbenshade, AJ. Pediatric Blood and Cancer. 2024; 71:e30818.

Impact of Time-to-Antibiotic Delivery in Pediatric Patients With Cancer Presenting With Febrile Neutropenia. De Castro, GC; Slatnick, LR; Shannon, M; Zhao, Z; Jackson, K; Smith, CM; Whitehurst, D; Elliott, C; Clark, CC; Scott, HF; Friedman, DL; Demedis, J; Esbenshade, AJ. JCO Oncology Practice. 2024; 20:228-238.

1702. Disseminated Candidiasis after Candidemia: Epidemiology, Diagnostic Evaluation, and Risk Factors. Whitehurst, D; Murphy, CR; Teoh, Z; Brammer, CN; Perkins, K; Paulsen, GC; Danziger-Isakov, LA; Miller-Handley, H; Otto, WR. Open Forum Infectious Diseases. 2023; 10:ofad500.1535.